SAR3419

· Sanofi

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SAR3419, covering 2012-02-14 to 2018-01-25. Get the full timeline:

Most recent: Clinical Trial Update: SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients [Phase 2]